Suppr超能文献

褪黑素对糖尿病认知障碍患者肠道微生物群和代谢组学的影响。

Effect of melatonin on gut microbiome and metabolomics in diabetic cognitive impairment.

作者信息

Gao Ming, Li Jie, Han Xu, Zhang Beiyao, Chen Jinting, Lang Jiadong, Zhang Qiangqiang

机构信息

Department of Endocrinology and Rare Disease, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Hebei Key Laboratory of Rare Disease, Hebei Provincial Department of Science and Technology, Shijiazhuang, Hebei, China.

出版信息

Front Pharmacol. 2024 Nov 21;15:1489834. doi: 10.3389/fphar.2024.1489834. eCollection 2024.

Abstract

INTRODUCTION

Diabetic cognitive impairment(DCI) presents as a central nervous complication of diabetes especially among aging population. Melatonin (MEL) is known for its antioxidant and anti-inflammation effects in neuroprotective aspects. Recent evidence has demonstrated that the gut microbiome plays a key role in DCI by modulating cognitive function through the gut-brain crosstalk. MEL has been shown to modulate gut microbiota composition in diabetic model. However, the underlying mechanism through which the gut microbiome contributes to DCI remains unclear. This study aims to investigate the effect and mechanism of MEL in attenuating DCI in relation to regulating the gut microbiome and metabolomics.

METHODS

Cognitive and memory function were assessed by the Morris water maze test, histopathological assessment of brain tissues, and immunoblotting of neuroinflammation and apoptosis. The levels of serum tumor necrosis factor-α (TNF-α) and Interleukin-18 (IL-18) were measured by enzyme-linked immunoassays to reflect the circulatory inflammation level.16S rRNA microbiome sequencing analysis was performed on control mice(db-m group), diabetic mice(db-db group) and MEL-treated diabetic mice(db-dbMEL group). Gut metabolites changes were characterized using liquid chromatography tandem mass spectrometry (LC-MS/MS).

RESULTS

Our study confirmed that MEL alleviated diabetes-induced cognition and memory dysfunction. MEL protected against neuroinflammation and apoptosis in hippocampus of db-db mice. MEL corrected the increased abundance of and and the reduced abundance of in db-db mice. The vast majority of differential metabolites among the three groups were lipids and lipid-like molecules. MEL significantly restored the reduced levels of pyruvate and lactic acid.

DISCUSSION

Our results supported the use of MEL as a promising therapeutic agent for DCI, in which the underlying mechanism may be associated with gut microbiome and metabolomics regulation.

摘要

引言

糖尿病认知障碍(DCI)是糖尿病的一种中枢神经并发症,在老年人群中尤为常见。褪黑素(MEL)在神经保护方面具有抗氧化和抗炎作用。最近的证据表明,肠道微生物群通过肠-脑轴调节认知功能,在DCI中起关键作用。在糖尿病模型中,MEL已被证明可调节肠道微生物群组成。然而,肠道微生物群导致DCI的潜在机制仍不清楚。本研究旨在探讨MEL在调节肠道微生物群和代谢组学方面减轻DCI的作用及机制。

方法

通过莫里斯水迷宫试验、脑组织组织病理学评估以及神经炎症和细胞凋亡的免疫印迹法评估认知和记忆功能。采用酶联免疫吸附测定法测量血清肿瘤坏死因子-α(TNF-α)和白细胞介素-18(IL-18)水平,以反映循环炎症水平。对对照小鼠(db-m组)、糖尿病小鼠(db-db组)和MEL治疗的糖尿病小鼠(db-dbMEL组)进行16S rRNA微生物群测序分析。使用液相色谱串联质谱(LC-MS/MS)对肠道代谢物变化进行表征。

结果

我们的研究证实,MEL可减轻糖尿病诱导的认知和记忆功能障碍。MEL可保护db-db小鼠海马体免受神经炎症和细胞凋亡的影响。MEL纠正了db-db小鼠中[具体菌种1]和[具体菌种2]丰度的增加以及[具体菌种3]丰度的降低。三组之间绝大多数差异代谢物为脂质和类脂质分子。MEL显著恢复了丙酮酸和乳酸水平的降低。

讨论

我们的结果支持将MEL作为一种有前景的DCI治疗药物,其潜在机制可能与肠道微生物群和代谢组学调节有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1993/11619431/02759a915318/fphar-15-1489834-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验